Literature DB >> 22934376

Retrospective review of serum creatinine and creatinine-based measures of estimated glomerular filtration rate in an amputee population.

Ellen E Im1, Ian J Stewart, Benjamin D Morrow, Molly A Tilley, Kelly D Heegard, James K Aden, Kevin K Chung, Casey L Cotant.   

Abstract

A variety of equations are used to estimate glomerular filtration rate (eGFR). These formulas have never been validated in the setting of traumatic amputation. In this retrospective study involving 255 military personnel with traumatic amputations at a single outpatient center, muscle mass lost was estimated using percentage of estimated body weight lost (% EBWL). Serum creatinine (Scr) and eGFR by the Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations were compared to % EBWL for each patient. The average Scr for the group studied was also compared with a cohort matched for age, sex, and race from the Third National Health and Nutrition Examination Survey (NHANES III). Percentage EBWL correlated significantly with Scr (R2 = 0.095, p < 0.0001), eGFR by MDRD (R2 = 0.077, p < 0.0001), and eGFR by CKD-EPI (R2 = 0.074, p < 0.0001). The average Scr was significantly lower than a similar population from NHANES III (0.83 +/- 0.137 mg/dL vs. 1.14 +/- 0.127 mg/dL, p < 0.0001). Percentage EBWL has a significant correlation with Scr and eGFR by both the MDRD and CKD-EPI equations. Furthermore, patients with traumatic amputation have significantly lower Scr values than the general population. Creatinine-based estimators of GFR may overestimate renal function in the setting of traumatic amputation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22934376     DOI: 10.7205/milmed-d-11-00427

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  1 in total

1.  Comparison of 24-hour urinary creatinine clearance and estimated glomerular filtration rate based on a panel of filtration markers in patients with chronic kidney disease.

Authors:  Esben Iversen; Lene Boesby; Ditte Hansen; Morten Baltzer Houlind
Journal:  Pharmacol Res Perspect       Date:  2022-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.